Endocrine Abstracts

Background: Gestational diabetes mellitus (GDM) is common complication in pregnancy. During pandemic COVID-19, endocrine service iniciate telemedicine in medical care and monitoring blood glucose.

Purpose: The purpose of this study was to asses metabolic control and pregnancy outcome during pregnancy in telematic consult.

Materials and Methods: Descriptive study of 20 patients were assesed in telematic review in the first wave of the COVID-19. GDM was defined according to NDDG 1979. Glucose targets were defined by a capillary fasting glucose target <95 mg/dl and a 2-hour postprandial capillary glucose <120 mg/dl. Good control was defined as: < 5% of the glycemic values were not within the target range,

Results: 20 patients (age 36,6 ± 3.0 years; HbA1c levels 5.3% ±0.2).19 patient had a risk factors for predisposition to GDM include obesity (85%), history of gestational diabetes (50%) and family history of type 2 diabetes mellitus (45%). The week of the first consultation was on average at week 34 +/- 9.5. The median goal achievement was at week 37 [37-37,5] 19 had a good control and the mean dose of insulin for glycemic control was 13.05+-16.02 units. Non differences were found with respect to prolonged labor and preeclampsia with our prepandemic registration.

Conclusion: The first wave of the COVID-19 pandemic did not seem to have a negative impact on pregnancy outcomes in GDM women, despite patients with gestational diabetes were later referred to our clinics.